XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 936 $ 56,279 $ 309,764 $ 675 $ 367,654 $ 14,999 $ 382,653
Common shares outstanding at Dec. 31, 2020 9,363,717            
 Stock option grant compensation $ 0 52 0 0 52 0 52
 Restricted stock compensation 0 404 0 0 404 0 404
 Shares granted to Employees 0 50 0 0 50 0 50
 Restricted stock award 3 (3) 0 0 0 0 0
 Shares granted to Directors 1 499 0 0 500 0 500
 Exercise of stock options 1 268 0 0 269 0 269
 Net income 0 0 28,807 0 28,807 12,236 41,043
 Distributions to partners 0 0 0 0 0 (1,846) (1,846)
 Unrealized loss on investment, net $ 0 0 0 (482) (482) 0 (482)
Employee shares granted 1,098            
Restricted shares awarded 27,778            
Director shares granted 9,105            
Stock options exercised 15,334            
 Shares purchased and cancelled $ 0 (37) (227) 0 (264) 0 (264)
Shares purchased and cancelled (6,004)            
 Contributions from partners $ 0 0 0 0 0 4,551 4,551
Ending balance, value at Sep. 30, 2021 $ 941 57,512 338,344 193 396,990 29,940 426,930
Common shares outstanding at Sep. 30, 2021 9,411,028            
Beginning balance, value at Dec. 31, 2020 $ 936 56,279 309,764 675 367,654 14,999 382,653
Common shares outstanding at Dec. 31, 2020 9,363,717            
Ending balance, value at Dec. 31, 2021 $ 941 57,617 337,752 113 396,423 28,827 $ 425,250
Common shares outstanding at Dec. 31, 2021 9,411,028           9,411,028
Beginning balance, value at Jun. 30, 2021 $ 941 57,360 337,992 268 396,561 31,724 $ 428,285
Common shares outstanding at Jun. 30, 2021 9,411,028            
 Stock option grant compensation $ 0 17 0 0 17 0 17
 Restricted stock compensation 0 135 0 0 135 0 135
 Net income 0 0 352 0 352 (465) (113)
 Distributions to partners 0 0 0 0 0 (1,319) (1,319)
 Unrealized loss on investment, net 0 0 0 (75) (75) 0 (75)
Ending balance, value at Sep. 30, 2021 $ 941 57,512 338,344 193 396,990 29,940 426,930
Common shares outstanding at Sep. 30, 2021 9,411,028            
Beginning balance, value at Dec. 31, 2021 $ 941 57,617 337,752 113 396,423 28,827 $ 425,250
Common shares outstanding at Dec. 31, 2021 9,411,028           9,411,028
 Stock option grant compensation $ 0 52 0 0 52 0 $ 52
 Restricted stock compensation 0 550 0 0 550 0 550
 Shares granted to Employees 0 50 0 0 50 0 50
 Restricted stock award 2 (2) 0 0 0 0 0
 Shares granted to Directors 1 649 0 0 650 0 650
 Forfeiture of restricted stock award 0 0 0 0 0 0 0
 Exercise of stock options 1 232 0 0 233 0 233
 Net income 0 0 1,809 0 1,809 (439) 1,370
 Distributions to partners 0 0 0 0 0 (1,937) (1,937)
 Unrealized loss on investment, net $ 0 0 0 (1,533) (1,533) 0 (1,533)
Employee shares granted 865            
Restricted shares awarded 21,464            
Director shares granted 11,232            
Restricted stock forfeited (1,363)            
Stock options exercised 11,870            
Ending balance, value at Sep. 30, 2022 $ 945 59,148 339,561 (1,420) 398,234 26,451 $ 424,685
Common shares outstanding at Sep. 30, 2022 9,455,096           9,455,096
Beginning balance, value at Jun. 30, 2022 $ 945 58,872 339,081 (1,096) 397,802 27,135 $ 424,937
Common shares outstanding at Jun. 30, 2022 9,455,096            
 Stock option grant compensation $ 0 18 0 0 18 0 18
 Restricted stock compensation 0 258 0 0 258 0 258
 Net income 0 0 480 0 480 (96) 384
 Distributions to partners 0 0 0 0 0 (588) (588)
 Unrealized loss on investment, net 0 0 0 (324) (324) 0 (324)
Ending balance, value at Sep. 30, 2022 $ 945 $ 59,148 $ 339,561 $ (1,420) $ 398,234 $ 26,451 $ 424,685
Common shares outstanding at Sep. 30, 2022 9,455,096           9,455,096